Highlights:  IDT’s strategic pivot continues to gain momentum...

Highlights:
 IDT’s strategic pivot continues to gain momentum with the Company’s three business pillars recording significant growth in unaudited revenue in the September quarter
 Preliminary unaudited revenue rose for the 5th consecutive quarter – up ~300% to $3.0M in 1QFY24 vs. the previous corresponding period (pcp)
 IDT secured a further $2.1M in new contracts in the month of October and $4.2M at approval stage
 Sales pipeline continues to build with 75 leads generated and $11.3M in proposals in 1QFY24 alone
 IDT’s API pillar posted a 10-fold increase in unaudited revenue to $1.2M vs. pcp
 The Advanced Therapy pillar is gaining strong early traction with unaudited revenue jumping to $187K compared to $12K in the pcp, and this is expected to keep growing significantly over the coming quarters
 The Specialty Orals pillar, the largest contributor to group revenue, recorded a 200% pcp increase to >$1.4M